# Treatment Outcome in Major Depressive Disorder

> **NCT02869035** · PHASE1 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 100 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT02869035
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2019-07
- **Final completion:** 2019-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-10-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02869035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02869035, "Treatment Outcome in Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02869035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*